旅橙文化(08627.HK)预计中期由盈转亏不超300万元
格隆汇8月5日丨旅橙文化(08627.HK)发布公告,公司预期截至2020年6月30日止6个月将录得不超过人民币300万元的净亏损,上年同期纯利约人民币430万元。净亏损主要由于爆发新型冠状病毒(COVID-19)疫情引致集团营销服务新合约需求减少及集团现有项目遭延迟或取消,导致集团期间收入较2019年同期减少超过70%;及期间由于雇员人数增加而导致员工福利开支增加。疫情已对整体经济状况产生不利影响,而目前市场情绪低迷。由于疫情可能会持续一段时间,因此,疫情会对集团业务及财务表现产生影响的程度仍有待厘定。董事会正密切监察现时的情况,并会寻求适当的措施以减低疫情对集团的影响。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.